US · Healthcare

Actinium Pharmaceuticals Inc (ATNM)

Biotechnology

Actinium Pharmaceuticals Inc (ATNM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ATNM

P/E ratio

18.00

Actinium Pharmaceuticals Inc (ATNM) — FAQ

What is ATNM's P/E ratio?

The price-to-earnings (P/E) ratio for Actinium Pharmaceuticals Inc (ATNM) is 18.00 (data as of 2026-03-23).

Does Actinium Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Actinium Pharmaceuticals Inc (ATNM). Check the MyAverix Finance app for the latest dividend data.

What sector is Actinium Pharmaceuticals Inc in?

Actinium Pharmaceuticals Inc (ATNM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ATNM listed on?

ATNM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)